Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Submit a comment

On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA)
Anthony Sebastian, … , Elisabeth McSherry, R. Curtis Morris Jr.
Anthony Sebastian, … , Elisabeth McSherry, R. Curtis Morris Jr.
Published January 1, 1971
Citation Information: J Clin Invest. 1971;50(1):231-243. https://doi.org/10.1172/JCI106479.
View: Text | PDF
Research Article

On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA)

  • Text
  • PDF
Abstract

The mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA) was investigated in 10 patients, each of whom had impaired proximal renal tubular reabsorption of bicarbonate as judged from a greater than 15-20% reduction of renal tubular bicarbonate reabsorption (THCO3-) at normal plasma bicarbonate concentrations. When the plasma bicarbonate concentration ([HCO3-]p) was experimentally increased to normal levels in three patients with a fractional potassium excretion (CK/Cin) of less than 1.0 during acidosis, CK/Cin and urinary potassium excretion (UKV/Cin) increased strikingly and concurrently with a striking increase in urinary sodium (UNaV/Cin) and bicarbonate (UHCO3-V/Cin) excretion. When [HCO3-]p was increased to normal levels in two patients with a CK/Cin of greater than 1.0 during acidosis and in whom UNaV/Cin and UHCO3-V/Cin were already markedly increased, CK/Cin did not increase further. When [HCO3-]p was decreased to subnormal levels in a patient given ammonium chloride, UKV/Cin, CK/Cin, and UHCO3-V/Cin decreased concurrently. In the six patients in whom [HCO3-]p was maintained at normal levels (oral alkali therapy) for 2 months or longer, CK/Cin was directly related to the urinary excretion rates of sodium and bicarbonate, hence was directly related to the magnitude of reduction of THCO3- at normal [HCO3-]p; CK/Cin was greater than 0.55 in all six patients and greater than 1.0 in four.

Authors

Anthony Sebastian, Elisabeth McSherry, R. Curtis Morris Jr.

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts